Kerala government panel to suggest PPP model to set up COVID-19 vaccine production units

Express News Service
THIRUVANANTHAPURAM:  The five-member committee formed by the government to explore the possibility of developing a vaccine against COVID-19 has concluded that it is impractical at this stage.
However, it will recommend to set up vaccine manufacturing units on public-private partnership (PPP) model with the manufactures of the vaccine candidates that are in trial phase. On November 16, the state constituted a five-member committee to explore possibilities of collaborations for vaccine production and having a vaccine development unit, including protein-based biologicals like enzymes and cancer drugs.
"There are some practical difficulties. The vaccine is the need of the hour. For developing it, painstaking research efforts, resources and funds are required. Most importantly, it will take time," said a member of the committee. 

Related Keywords

Sabarimala ,Kerala ,India ,Thiruvananthapuram ,Vellore ,Tamil Nadu ,Bharat ,Zydus Cadila ,T Jacob John ,Dileepv Kumar ,Public Health Lab ,Christian Medical College ,Institute Of Advanced Virology ,News Service ,Serum Institute Of India ,Kerala State Drugs ,Pharmaceuticals Limited ,Advanced Virology ,State Public Health Lab ,Serum Institute ,Bharat Biotech ,சபரிமாலா ,கேரள ,இந்தியா ,திருவனந்தபுரம் ,வேலூர் ,தமிழ் நாடு ,பாரத் ,ஜய்துச் காடிலா ,டி ஜாகோப் ஜான் ,பொது ஆரோக்கியம் ஆய்வகம் ,கிறிஸ்துவர் மருத்துவ கல்லூரி ,செய்தி சேவை ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,கேரள நிலை மருந்துகள் ,மருந்துகள் வரையறுக்கப்பட்டவை ,நிலை பொது ஆரோக்கியம் ஆய்வகம் ,சீரம் நிறுவனம் ,பாரத் பயோடெக் ,